The Manufacturers Life Insurance Company Has $60.45 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

The Manufacturers Life Insurance Company cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 148,744 shares of the company’s stock after selling 5,609 shares during the period. The Manufacturers Life Insurance Company owned about 0.06% of HCA Healthcare worth $60,454,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare during the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $28,000. Bangor Savings Bank lifted its holdings in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC increased its stake in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares during the period. Finally, Capital Performance Advisors LLP acquired a new position in shares of HCA Healthcare during the third quarter valued at $41,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 1.1 %

Shares of NYSE:HCA opened at $325.35 on Thursday. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14. The stock has a market capitalization of $82.41 billion, a PE ratio of 14.61, a price-to-earnings-growth ratio of 1.25 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company’s 50-day moving average price is $374.98 and its two-hundred day moving average price is $358.51.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Analyst Ratings Changes

A number of research analysts have issued reports on HCA shares. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $400.00 to $320.00 in a research report on Monday. Oppenheimer lifted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. Morgan Stanley started coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price for the company. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Finally, StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, five have given a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $380.29.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The trade was a 21.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,155 shares of company stock worth $5,608,990. Company insiders own 1.70% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.